Onderneming T2 Biosystems, Inc.
Aandelen
TTOO
US89853L3024
Geavanceerde medische apparatuur & technologie
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,92 USD | +6,57% | -2,03% | -53,78% |
Vakgebied
Aantal werknemers: 113
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Consumables
67,3
%
| 8 | 36,7 % | 5 | 67,3 % | -40,84% |
Instruments
18,5
%
| 2 | 10,3 % | 1 | 18,5 % | -42,31% |
Service
6,6
%
| 1 | 3,1 % | 0 | 6,6 % | -31,41% |
Contribution
5,9
%
| 11 | 49,5 % | 0 | 5,9 % | -96,17% |
Instrument Rentals
1,7
%
| 0 | 0,3 % | 0 | 1,7 % | +58,97% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
62,5
%
| 18 | 82,5 % | 4 | 62,5 % | -75,59% |
International
37,5
%
| 4 | 17,5 % | 3 | 37,5 % | -30,77% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Sperzel
CEO | Chief Executive Officer | 60 | 08-01-20 |
John Sprague
DFI | Director of Finance/CFO | 65 | 30-01-18 |
Roger Smith
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-01-14 |
Kelley Morgan
HRO | Human Resources Officer | - | 01-03-14 |
Matthew McKillip
SAM | Sales & Marketing | - | - |
Michael Gibbs
LAW | General Counsel | 53 | 01-12-14 |
Brett Giffin
PRN | Corporate Officer/Principal | 66 | 08-11-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Elsbree
BRD | Director/Board Member | 76 | 01-07-14 |
Seymour Liebman
BRD | Director/Board Member | 74 | 21-09-16 |
Robin Toft
BRD | Director/Board Member | 63 | 14-06-20 |
John Cumming
BRD | Director/Board Member | 78 | 01-07-14 |
Ninfa Saunders
BRD | Director/Board Member | 72 | 14-06-20 |
John Sperzel
CEO | Chief Executive Officer | 60 | 08-01-20 |
Laura Adams
BRD | Director/Board Member | 67 | 18-10-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 8 792 950 | 4 315 769 ( 49,08 %) | 0 | 49,08 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-53,78% | 24,09 mln. | |
+7,95% | 218 mld. | |
+6,89% | 182 mld. | |
+11,73% | 132 mld. | |
+26,95% | 108 mld. | |
+12,55% | 52,98 mld. | |
-0,62% | 47,59 mld. | |
-0,67% | 39,96 mld. | |
+12,29% | 39,22 mld. | |
+26,31% | 26,94 mld. |
- Beurs
- Aandelen
- Koers TTOO
- Onderneming T2 Biosystems, Inc.